120 related articles for article (PubMed ID: 2486472)
41. Radiation therapy for primary non-Hodgkin's lymphoma of the head and neck in stages I and II.
Sakata K; Akanuma A; Aoki Y; Karasawa K; Nakagawa K; Muta N; Iio M; Mohri N
Radiat Med; 1989; 7(6):287-92. PubMed ID: 2633216
[TBL] [Abstract][Full Text] [Related]
42. Is comprehensive lymphatic irradiation for low-grade non-Hodgkin's lymphoma curative therapy? Long-term experience at a single institution.
De Los Santos JF; Mendenhall NP; Lynch JW
Int J Radiat Oncol Biol Phys; 1997 Apr; 38(1):3-8. PubMed ID: 9211997
[TBL] [Abstract][Full Text] [Related]
43. Outcomes of patients with non-Hodgkin's lymphoma treated with Bexxar with or without external-beam radiotherapy.
Smith K; Byer G; Morris CG; Kirwan JM; Lightsey J; Mendenhall NP; Hoppe BS; Lynch J; Olivier K
Int J Radiat Oncol Biol Phys; 2012 Mar; 82(3):1122-7. PubMed ID: 21570217
[TBL] [Abstract][Full Text] [Related]
44. Prognostic factors in patients with early stage non-Hodgkin's lymphomas of the head and neck treated with definitive irradiation.
Goldwein JW; Coia LR; Hanks GE
Int J Radiat Oncol Biol Phys; 1991 Jan; 20(1):45-51. PubMed ID: 1993630
[TBL] [Abstract][Full Text] [Related]
45. Radiotherapy for primary localized (stage I and II) non-Hodgkin's lymphoma of the oral cavity.
Sunaba K; Shibuya H; Okada N; Amagasa T; Enomoto S; Kishimoto S
Int J Radiat Oncol Biol Phys; 2000 Apr; 47(1):179-83. PubMed ID: 10758321
[TBL] [Abstract][Full Text] [Related]
46. Treatment results of tonsillar lymphoma: a 10-year experience.
Mohammadianpanah M; Omidvai S; Mosalei A; Ahmadloo N
Ann Hematol; 2005 Apr; 84(4):223-6. PubMed ID: 15042316
[TBL] [Abstract][Full Text] [Related]
47. Primary non-Hodgkin's lymphoma of bone. A clinicopathologic study.
Baar J; Burkes RL; Bell R; Blackstein ME; Fernandes B; Langer F
Cancer; 1994 Feb; 73(4):1194-9. PubMed ID: 8313322
[TBL] [Abstract][Full Text] [Related]
48. Non-Hodgkin's lymphoma of the thyroid gland: prognostic factors and treatment outcome. The Princess Margaret Hospital Lymphoma Group.
Tsang RW; Gospodarowicz MK; Sutcliffe SB; Sturgeon JF; Panzarella T; Patterson BJ
Int J Radiat Oncol Biol Phys; 1993 Oct; 27(3):599-604. PubMed ID: 8226154
[TBL] [Abstract][Full Text] [Related]
49. Long-term follow-up of a prospective study of combined modality therapy for stage I-II indolent non-Hodgkin's lymphoma.
Seymour JF; Pro B; Fuller LM; Manning JT; Hagemeister FB; Romaguera J; Rodriguez MA; Ha CS; Smith TL; Ayala A; Hess M; Cox JD; Cabanillas F; McLaughlin P
J Clin Oncol; 2003 Jun; 21(11):2115-22. PubMed ID: 12775737
[TBL] [Abstract][Full Text] [Related]
50. [Prognosis and treatment strategies of primary B-cell and NK/T-cell nasopharyngeal non-Hodgkin's lymphoma at early stage].
Zou GR; Zhang YJ; Xie FY; Zheng W; Li HX; Xia YF; Lin TY; Lu TX
Ai Zheng; 2006 Dec; 25(12):1543-9. PubMed ID: 17166383
[TBL] [Abstract][Full Text] [Related]
51. Prognostic factors in stage I and II high and intermediate grade non-Hodgkin's lymphoma.
Mackintosh JF; Cowan RA; Jones M; Harris M; Deakin DP; Crowther D
Eur J Cancer Clin Oncol; 1988 Oct; 24(10):1617-22. PubMed ID: 3208806
[TBL] [Abstract][Full Text] [Related]
52. Curative radiotherapy for primary orbital lymphoma.
Bhatia S; Paulino AC; Buatti JM; Mayr NA; Wen BC
Int J Radiat Oncol Biol Phys; 2002 Nov; 54(3):818-23. PubMed ID: 12377334
[TBL] [Abstract][Full Text] [Related]
53. Abdominal irradiation after chemotherapy in non-Hodgkin's lymphoma: review of 32 patients.
Brihi E; Akoum R; Saade M; Chahine G
Mol Immunol; 2003 Jul; 39(17-18):1121-8. PubMed ID: 12835089
[TBL] [Abstract][Full Text] [Related]
54. Patterns of failure following high-dose chemotherapy and autologous bone marrow transplantation with involved field radiotherapy for relapsed/refractory Hodgkin's disease.
Mundt AJ; Sibley G; Williams S; Hallahan D; Nautiyal J; Weichselbaum RR
Int J Radiat Oncol Biol Phys; 1995 Sep; 33(2):261-70. PubMed ID: 7673013
[TBL] [Abstract][Full Text] [Related]
55. Non-Hodgkin's lymphoma of Waldeyer's ring in children: outcome using chemotherapy and involved field radiotherapy.
Laskar S; Bahl G; Muckaden MA; Pai S; Nair R; Gupta S; Shet T; Gujral S; Arora B; Sengar M; Shrivastava SK; Dinshaw KA
Clin Oncol (R Coll Radiol); 2008 Oct; 20(8):613-8. PubMed ID: 18585015
[TBL] [Abstract][Full Text] [Related]
56. Primary gastric non-Hodgkin's lymphoma stage IE and IIE.
Lybeert ML; De Neve W; Vrints LW; Coen V; Coebergh JW
Eur J Cancer; 1996 Dec; 32A(13):2306-11. PubMed ID: 9038614
[TBL] [Abstract][Full Text] [Related]
57. Ocular adnexal lymphoma: clinical behavior of distinct World Health Organization classification subtypes.
Fung CY; Tarbell NJ; Lucarelli MJ; Goldberg SI; Linggood RM; Harris NL; Ferry JA
Int J Radiat Oncol Biol Phys; 2003 Dec; 57(5):1382-91. PubMed ID: 14630277
[TBL] [Abstract][Full Text] [Related]
58. Suprahyoid Hodgkin's disease stage IA.
Bessell EM; MacLennan KA; Toghill PJ; Ellis IO; Fletcher J; Dowling FD
Radiother Oncol; 1991 Nov; 22(3):190-4. PubMed ID: 1771260
[TBL] [Abstract][Full Text] [Related]
59. Low grade stage I and II non-Hodgkin's lymphoma: results of treatment and relapse pattern following therapy.
Taylor RE; Allan SG; McIntyre MA; Kerr GR; Taylor AJ; Ritchie GL; Leonard RC
Clin Radiol; 1988 May; 39(3):287-90. PubMed ID: 3396280
[TBL] [Abstract][Full Text] [Related]
60. [Results of the treatment of localized non-Hodgkin's lymphoma originated in the thyroid gland].
Ikeda H; Masaki N; Aozasa K
Gan No Rinsho; 1988 Apr; 34(5):637-43. PubMed ID: 3290532
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
